Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China. The company develops ophthalmic anti-infective drugs, other ophthalmic drugs, nonsteroidal anti-inflammatory drugs for ophthalmology, mydriatic and ciliary muscle paralytic drugs, ophthalmic anti-inflammatory/anti-infective compound drugs, dry eye products, miotic and anti-glaucoma drugs, and other drugs. It also develops products, such as Zirun, a Cyclosporine eye drops; Sugaojie, a calf blood deproteinized extract eye gel/eye drops; Diyou eye gel; Difei eye drops; and Ziyang, a vitamin A palmitate eye gel. In addition, the company is involved in Ophthalmology hospital services; sale of medicines, health foods, and medical devices; operation of telecommunications business; and optometry and glasses services. The company was founded in 1977 and is headquartered in Shenyang, the People’s Republic of China.
Metrics to compare | 300573 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300573PeersSector | |
---|---|---|---|---|
P/E Ratio | 34.5x | 46.5x | −0.5x | |
PEG Ratio | 0.46 | −1.21 | 0.00 | |
Price/Book | 8.9x | 2.5x | 2.6x | |
Price / LTM Sales | 7.3x | 4.8x | 3.3x | |
Upside (Analyst Target) | - | −0.9% | 40.6% | |
Fair Value Upside | Unlock | 0.0% | 5.3% | Unlock |